Abstract
Consumption of industrially produced trans-fatty acids (TFA) is associated with substantial risk of coronary heart disease (CHD). The magnitude of this relationship, as well as emerging associations with end points such as diabetes and sudden cardiac death, cannot be fully explained by the well-established adverse effects of TFA on serum lipids. We review the evidence for effects of TFA intake on nonlipid risk factors. Based on evidence from randomized controlled trials, observational studies, animal experiments, and in vitro studies, these include effects on systemic inflammation, endothelial dysfunction, visceral adiposity, insulin resistance, and arrhythmic risk. The types and strength of evidence for each of these nonlipid effects varies, but the overall constellation of findings is qualitatively and quantitatively unique among dietary fats. The multiple adverse effects and implicated pathways are consistent with the observed strong associations of TFA consumption with CHD risk. These nonlipid effects also explain why TFA consumption may adversely impact other non-CHD diseases and end points.
Similar content being viewed by others
References and Recommended Reading
Mozaffarian D, Katan MB, Ascherio A, et al.: Trans fatty acids and cardiovascular disease. N Engl J Med 2006, 354:1601–1613.
Mozaffarian D, Abdollahi M, Campos H, et al.: Consumption of trans fats and estimated effects on coronary heart disease in Iran. Eur J Clin Nutr 2007, 61:1004–1010.
Mozaffarian D, Clarke R: Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. Eur J Clin Nutr 2009, 63(Suppl 2):S22–S33.
Allison DB, Egan SK, Barraj LM, et al.: Estimated intakes of trans fatty and other fatty acids in the US population. J Am Diet Assoc 1999, 99:166–174; quiz 175–176.
Micha R, Mozaffarian D: Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes. Nat Rev Endocrinol 2009, 5:335–344.
Baer DJ, Judd JT, Clevidence BA, et al.: Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am J Clin Nutr 2004, 79:969–973.
Han SN, Leka LS, Lichtenstein AH, et al.: Effect of hydrogenated and saturated, relative to polyunsaturated, fat on immune and inflammatory responses of adults with moderate hypercholesterolemia. J Lipid Res 2002, 43:445–452.
Lichtenstein AH, Erkkilä AT, Lamarche B, et al.: Influence of hydrogenated fat and butter on CVD risk factors: remnant-like particles, glucose and insulin, blood pressure and C-reactive protein. Atherosclerosis 2003, 171:97–107.
Dlouhy P, Kucera P, Kraml P, et al.: Short-term dietary intake of C18:1 trans fatty acids decreases the function of cellular immunity in healthy young men. Ann Nutr Metab 2008, 53:129–136.
Mozaffarian D, Pischon T, Hankinson SE, et al.: Dietary intake of trans fatty acids and systemic inflammation in women. Am J Clin Nutr 2004, 79:606–612.
Lopez-Garcia E, Schulze MB, Meigs JB, et al.: Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr 2005, 135:562–566.
Esmaillzadeh A, Azadbakht L: Home use of vegetable oils, markers of systemic inflammation, and endothelial dysfunction among women. Am J Clin Nutr 2008, 88:913–921.
Mozaffarian D, Rimm EB, King IB, et al.: Trans fatty acids and systemic inflammation in heart failure. Am J Clin Nutr 2004, 80:1521–1525.
Kummerow FA, Zhou Q, Mahfouz MM, et al.: Trans fatty acids in hydrogenated fat inhibited the synthesis of the polyunsaturated fatty acids in the phospholipid of arterial cells. Life Sci 2004, 74:2707–2723.
Decsi T, Boehm G, Tjoonk HM, et al.: Trans isomeric octadecenoic acids are related inversely to arachidonic acid and DHA and positively related to mead acid in umbilical vessel wall lipids. Lipids 2002, 37:959–965.
Innis SM: Trans fatty intakes during pregnancy, infancy and early childhood. Atheroscler Suppl 2006, 7:17–20.
Kummerow FA, Mahfouz MM, Zhou Q: Trans fatty acids in partially hydrogenated soybean oil inhibit prostacyclin release by endothelial cells in presence of high level of linoleic acid. Prostaglandins Other Lipid Mediat 2007, 84:138–153.
Mahfouz MM, Kummerow FA: Hydrogenated fat high in trans monoenes with an adequate level of linoleic acid has no effect on prostaglandin synthesis in rats. J Nutr 1999, 129:15–24.
Balazy M, Chemtob S: Trans-arachidonic acids: new mediators of nitro-oxidative stress. Pharmacol Ther 2008, 119:275–290.
Vanden Heuvel JP: Diet, fatty acids, and regulation of genes important for heart disease. Curr Atheroscler Rep 2004, 6:432–440.
Koppe SP, Elias M, Moseley RH, and Green RM: Trans fat feeding results in higher serum alanine aminotransferase and increased insulin resistance compared with a standard murine high-fat diet. Am J Physiol Gastrointest Liver Physiol 2009, 297:G378–G384.
de Roos NM, Bots ML, Katan MB: Replacement of dietary saturated fatty acids by trans fatty acids lowers serum HDL cholesterol and impairs endothelial function in healthy men and women. Arterioscler Thromb Vasc Biol 2001, 21:1233–1237.
de Roos NM, Siebelink E, Bots ML, et al.: Trans monounsaturated fatty acids and saturated fatty acids have similar effects on postprandial flow-mediated vasodilation. Eur J Clin Nutr 2002, 56:674–679.
Keogh JB, Grieger JA, Noakes M, et al.: Flow-mediated dilatation is impaired by a high-saturated fat diet but not by a high-carbohydrate diet. Arterioscler Thromb Vasc Biol 2005, 25:1274–1279.
Dyerberg J, Eskesen DC, Andersen PW, et al.: Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8 weeks dietary intervention study. Eur J Clin Nutr 2004, 58:1062–1070.
Harvey KA, Arnold T, Rasool T, et al.: Trans-fatty acids induce pro-inflammatory responses and endothelial cell dysfunction. Br J Nutr 2008, 99:723–731.
Kummerow FA, Zhou Q, Mahfouz MM: Effect of trans fatty acids on calcium influx into human arterial endothelial cells. Am J Clin Nutr 1999, 70:832–838.
Zapolska-Downar D, Kosmider A, Naruszewicz M: Trans fatty acids induce apoptosis in human endothelial cells. J Physiol Pharmacol 2005, 56:611–625.
Kavanagh K, Jones KL, Sawyer J, et al.: Trans fat diet induces abdominal obesity and changes in insulin sensitivity in monkeys [abstract]. Obesity 2007, 15:1675–1684.
Axen KV, Dikeakos A, Sclafani A: High dietary fat promotes Syndrome X in nonobese rats. J Nutr 2003, 133:2244–2249.
Tetri LH, Basaranoglu M, Brunt EM, et al.: Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Am J Physiol Gastrointest Liver Physiol 2008, 295:G987–G995.
Okada T, Noguchi R, Hosokawa M, et al.: Effects of trans and conjugated LC N-3 polyunsaturated fatty acids on lipid composition and abdominal fat weight in rats. J Food Sci 2008, 73:H201–H206.
Koh-Banerjee P, Chu NF, Spiegelman D, et al.: Prospective study of the association of changes in dietary intake, physical activity, alcohol consumption, and smoking with 9-y gain in waist circumference among 16,587 US men. Am J Clin Nutr 2003, 78:719–727.
Field AE, Willett WC, Lissner L, et al.: Dietary fat and weight gain among women in the Nurses’ Health Study [abstract]. Obesity 2007, 15:967–976.
Christiansen E, Schnider S, Palmvig B, et al.: Intake of a diet high in trans monounsaturated fatty acids or saturated fatty acids. Effects on postprandial insulinemia and glycemia in obese patients with NIDDM. Diabetes Care 1997, 20:881–887.
Lefevre M, Lovejoy JC, Smith SR, et al.: Comparison of the acute response to meals enriched with cis- or trans-fatty acids on glucose and lipids in overweight individuals with differing FABP2 genotypes. Metabolism 2005, 54:1652–1658.
Vega-Lopez S, Ausman LM, Jalbert SM, et al.: Palm and partially hydrogenated soybean oils adversely alter lipoprotein profiles compared with soybean and canola oils in moderately hyperlipidemic subjects. Am J Clin Nutr 2006, 84:54–62.
Louheranta AM, Turpeinen AK, Vidgren HM, et al.: A high-trans fatty acid diet and insulin sensitivity in young healthy women. Metabolism 1999, 48:870–875.
Lovejoy JC, Smith SR, Champagne CM, et al.: Effects of diets enriched in saturated (palmitic), monounsaturated (oleic), or trans (elaidic) fatty acids on insulin sensitivity and substrate oxidation in healthy adults. Diabetes Care 2002, 25:1283–1288.
Tardy AL, Lambert-Porcheron S, Malpuech-Brugere C, et al.: Dairy and industrial sources of trans fat do not impair peripheral insulin sensitivity in overweight women. Am J Clin Nutr 2009, Am J Clin Nutr 2009, 27:515.
Esmaillzadeh A, Azadbakht L: Consumption of hydrogenated versus nonhydrogenated vegetable oils and risk of insulin resistance and the metabolic syndrome among Iranian adult women. Diabetes Care 2008, 31:223–226.
Radesky JS, Oken E, Rifas-Shiman SL, et al.: Diet during early pregnancy and development of gestational diabetes. Paediatr Perinat Epidemiol 2008, 22:47–59.
van Dam RM, Willett WC, Rimm EB, et al.: Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care 2002, 25:417–424.
Meyer KA, Kushi LH, Jacobs DR, et al.: Dietary fat and incidence of type 2 diabetes in older Iowa women. Diabetes Care 2001, 24:1528–1535.
Salmeron J, Hu FB, Manson JE, et al.: Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr 2001, 73:1019–1026.
Roberts TL, Wood DA, Riemersma RA, et al.: Trans isomers of oleic and linoleic acids in adipose tissue and sudden cardiac death. Lancet 1995, 345:278–282.
Lemaitre RN, King IB, Raghunathan TE, et al.: Cell membrane trans-fatty acids and the risk of primary cardiac arrest. Circulation 2002, 105:697–701.
Lemaitre RN, King IB, Mozaffarian D, et al.: Plasma phospholipid trans fatty acids, fatal ischemic heart disease, and sudden cardiac death in older adults: the Cardiovascular Health Study. Circulation 2006, 114:209–215.
Katz AM: Should trans fatty acids be viewed as membraneactive drugs? Atheroscler Suppl 2006, 7:41–42.
Katz AM, Nash-Adler P, Watras J, et al.: Fatty acid effects on calcium influx and efflux in sarcoplasmic reticulum vesicles from rabbit skeletal muscle. Biochim Biophys Acta 1982, 687:17–26.
Niu SL, Mitchell DC, Litman BJ: Trans fatty acid derived phospholipids show increased membrane cholesterol and reduced receptor activation as compared to their cis analogs. Biochemistry 2005, 44:4458–4465.
Morris MC, Evans DA, Tangney CC, et al.: Dietary copper and high saturated and trans fat intakes associated with cognitive decline. Arch Neurol 2006, 63:1085–1088.
Williams MA, King IB, Sorensen TK, et al.: Risk of preeclampsia in relation to elaidic acid (trans fatty acid) in maternal erythrocytes. Gynecol Obstet Invest 1998, 46:84–87.
Mahomed K, Williams MA, King IB, et al.: Erythrocyte omega-3, omega-6 and trans fatty acids in relation to risk of preeclampsia among women delivering at Harare Maternity Hospital, Zimbabwe. Physiol Res 2007, 56:37–50.
Mozaffarian D, Willett WC: Trans fatty acids and cardiovascular risk: a unique cardiometabolic imprint? Curr Atheroscler Rep 2007, 9:486–493.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wallace, S.K., Mozaffarian, D. Trans-fatty acids and nonlipid risk factors. Curr Atheroscler Rep 11, 423–433 (2009). https://doi.org/10.1007/s11883-009-0064-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11883-009-0064-0